about
Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuseNatural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief OverviewMagnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers.Synaptic Plasticity and Neurological Disorders in Neurotropic Viral InfectionsTargeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro studyβ-Amyloid1-42, HIV-1Ba-L (clade B) infection and drugs of abuse induced degeneration in human neuronal cells and protective effects of ashwagandha (Withania somnifera) and its constituent Withanolide AVorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder.Current status of non-viral gene therapy for CNS disorders.Pediatric neurocysticercosis: usefulness of antibody response in cysticidal treatment follow-up.Immunoneuropathogenesis of HIV-1 clades B and C: role of redox expression and thiol modification.Sterile alpha motif and histidine/aspartic acid domain-containing protein 1 (SAMHD1)-facilitated HIV restriction in astrocytes is regulated by miRNA-181a.Electrochemical sensing method for point-of-care cortisol detection in human immunodeficiency virus-infected patients.Ashwagandha (Withania somnifera) reverses β-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND).Sustained-release nanoART formulation for the treatment of neuroAIDSDrugs of Abuse in HIV infection and neurotoxicity.Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update.HIV-1 gp120 and morphine induced oxidative stress: role in cell cycle regulation.DJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine.HIV-1 subtypes B and C Tat differentially impact synaptic plasticity expression and implicates HIV-associated neurocognitive disorders.Profile of Class I Histone Deacetylases (HDAC) by Human Dendritic Cells after Alcohol Consumption and In Vitro Alcohol Treatment and Their Implication in Oxidative Stress: Role of HDAC Inhibitors Trichostatin A and Mocetinostat.Coupling of transient near infrared photonic with magnetic nanoparticle for potential dissipation-free biomedical application in brainPreparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue.Downregulation of host tryptophan-aspartate containing coat (TACO) gene restricts the entry and survival of Leishmania donovani in human macrophage model.Therapeutical Neurotargeting via Magnetic Nanocarrier: Implications to Opiate-Induced Neuropathogenesis and NeuroAIDS.Alcohol and Cannabinoids Differentially Affect HIV Infection and Function of Human Monocyte-Derived Dendritic Cells (MDDC).Effect of Cocaine on HIV Infection and Inflammasome Gene Expression Profile in HIV Infected MacrophagesHIV and Cocaine Impact Glial Metabolism: Energy Sensor AMP-activated protein kinase Role in Mitochondrial Biogenesis and Epigenetic RemodelingDevelopment of TIMP1 magnetic nanoformulation for regulation of synaptic plasticity in HIV-1 infection.Electrochemical monitoring-on-chip (E-MoC) of HIV-infection in presence of cocaine and therapeutics.Investigation of ac-magnetic field stimulated nanoelectroporation of magneto-electric nano-drug-carrier inside CNS cells.Cell cycle checkpoints and pathogenesis of HIV-1 infection: a brief overview.Editorial: HIV and Illicit Drugs of Abuse.Enhanced blood-brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulation.Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS.Novel nanoformulation to mitigate co-effects of drugs of abuse and HIV-1 infection: towards the treatment of NeuroAIDS.Investigation of Neuropathogenesis in HIV-1 Clade B and C Infection Associated with IL-33 and ST2 Regulation.Oxidative stress in HIV Infection and Alcohol Use: Role of Redox Signals in Modulation of Lipid Rafts and ABC-Transporters.Characterization of Nanodiamond-based anti-HIV drug Delivery to the Brain.Multifunctional Nanotherapeutics for the Treatment of neuroAIDS in Drug AbusersWithaferin A Suppresses Beta Amyloid in APP Expressing Cells: Studies for Tat and Cocaine Associated Neurological Dysfunctions
P50
Q26746336-438D0CDE-D91C-4DCE-8F49-25EE4C038A71Q26770401-168930DE-9DC4-47DA-B923-F192ACE420C1Q27317660-0C06DB70-3BAF-4543-9DF3-F54C732CE9D0Q28088477-EC1261A0-D75D-43A8-BA26-F57A94B16B89Q28487323-1D47CCC6-9521-4B20-8E56-D5226A6141E0Q28545117-7039F597-93E7-44FF-B0E0-A78EF7C7AED9Q33694166-A3778B37-556A-42CE-BED9-41286B04A276Q33824159-51B3F878-1024-4B27-A9F7-A2977C35F311Q34151387-EF5FB6E0-D4C0-4257-9EA1-7DBE4C47BE97Q34415545-0FFC2FAB-4F18-4691-9242-B4694A58BB93Q34472532-6AD6ADB6-1F09-4409-B8F7-7918A1720AB1Q35006408-C7116642-F030-49D0-A95D-A8986AF07C9DQ35023273-AA80514A-6AF1-4555-85EC-B0A2480CAB5DQ35082009-F34B6FE8-1096-4FB0-B5EA-F95E894457A2Q35212027-D6B3024A-723E-462C-B57E-7827809733E2Q35708840-F2816099-1642-47A2-BB58-1FC1F65A603BQ35770553-CC95D211-9C34-4789-A7A2-BE3BD68D2BF2Q35895155-EB6AD008-01EE-437B-9CE3-E98DA8D9CDD0Q36010129-3B78CE24-C80A-4B96-93FC-38D89B0C84CFQ36036559-57A4B18D-B61E-4186-AB9B-2935963E151BQ36087856-A49DA5AC-4D7E-426D-BC8A-60D82A6AEAC0Q36093283-C1CADD20-BDF0-4441-8142-D0E6A5E1C1E4Q36149705-1B7422E5-E22E-4769-88A8-309B8463A438Q36218958-1B9A10ED-5F37-4C7E-BC26-25B456B17652Q36392409-E0B4AF85-8BE9-4D30-9621-336F70EB3F23Q37019304-21AD37BB-65DE-4143-9067-DF20CA51E32AQ37184831-5FD894EB-D490-40A7-92B0-0E2CF470CF04Q37234713-98AD1A9B-6009-4CDE-A4C8-43684778FDCCQ37266049-BF9F9FC3-B56F-4715-BE04-1424D058CD95Q37736617-12CE0458-20E3-419F-99DC-AED87E25EC52Q38232164-B26141B2-F436-46EC-8650-C86E310993A4Q38886287-AEF8936E-BF75-4F51-9A7C-79B844401CD4Q39276123-60479D94-8BC3-4A06-B144-6AB6506651A3Q40089319-39501721-E6C9-482C-ABAB-C5549ADB4A59Q40111779-D3A7D548-73A8-43BA-AAF2-94490CF14FB6Q41140334-B4A402E1-AB8D-46AC-AD64-7727234DA91CQ46262611-B99A7A56-FAD6-4E31-8591-BD482C8D149BQ47548818-EE1E3FBD-E60C-4AFB-9D3F-F34D998E41C1Q56777442-5E2F155D-01FD-480C-A423-1B441499E139Q57821144-5E372C3F-0D88-42F0-936B-5CE249583F79
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Venkata Atluri
@ast
Venkata Atluri
@en
Venkata Atluri
@es
Venkata Atluri
@nl
Venkata Atluri
@sl
type
label
Venkata Atluri
@ast
Venkata Atluri
@en
Venkata Atluri
@es
Venkata Atluri
@nl
Venkata Atluri
@sl
prefLabel
Venkata Atluri
@ast
Venkata Atluri
@en
Venkata Atluri
@es
Venkata Atluri
@nl
Venkata Atluri
@sl
P106
P1153
55192724700
P31
P496
0000-0002-8070-6745